Brian D. Koh

1.2k total citations
17 papers, 942 citations indexed

About

Brian D. Koh is a scholar working on Molecular Biology, Oncology and Pharmacology. According to data from OpenAlex, Brian D. Koh has authored 17 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Pharmacology. Recurrent topics in Brian D. Koh's work include Acute Myeloid Leukemia Research (3 papers), DNA Repair Mechanisms (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Brian D. Koh is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), DNA Repair Mechanisms (3 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Brian D. Koh collaborates with scholars based in United States, United Kingdom and France. Brian D. Koh's co-authors include Craig M. Crews, Mikael Elofsson, Benjamin H. Kwok, MacKevin Ndubuisi, Scott H. Kaufmann, Judith E. Karp, Karen S. Flatten, Kevin L. Peterson, Allan D. Hess and B. Douglas Smith and has published in prestigious journals such as Journal of Biological Chemistry, Neuron and Blood.

In The Last Decade

Brian D. Koh

17 papers receiving 929 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian D. Koh United States 12 702 291 218 87 81 17 942
Linda Rickardson Sweden 18 705 1.0× 219 0.8× 290 1.3× 91 1.0× 82 1.0× 28 1.1k
Sundar Neelakantan United States 9 569 0.8× 403 1.4× 149 0.7× 90 1.0× 99 1.2× 15 830
Peng Zou China 13 644 0.9× 256 0.9× 208 1.0× 125 1.4× 69 0.9× 25 1.1k
Mohamed Elgendy Italy 13 766 1.1× 209 0.7× 199 0.9× 113 1.3× 79 1.0× 21 1.2k
Nengming Lin China 19 569 0.8× 173 0.6× 221 1.0× 72 0.8× 72 0.9× 55 870
Donghwa Kim South Korea 19 764 1.1× 192 0.7× 313 1.4× 86 1.0× 140 1.7× 42 1.3k
Joanna Zawacka‐Pankau Sweden 19 763 1.1× 236 0.8× 472 2.2× 51 0.6× 81 1.0× 32 1.2k
Jayshree L. Hirpara Singapore 16 746 1.1× 257 0.9× 204 0.9× 123 1.4× 38 0.5× 28 1.1k
Ayse Batova United States 18 603 0.9× 174 0.6× 232 1.1× 81 0.9× 156 1.9× 28 995
Manuela Gridling Austria 13 672 1.0× 97 0.3× 269 1.2× 108 1.2× 126 1.6× 17 1.0k

Countries citing papers authored by Brian D. Koh

Since Specialization
Citations

This map shows the geographic impact of Brian D. Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian D. Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian D. Koh more than expected).

Fields of papers citing papers by Brian D. Koh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian D. Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian D. Koh. The network helps show where Brian D. Koh may publish in the future.

Co-authorship network of co-authors of Brian D. Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Brian D. Koh. A scholar is included among the top collaborators of Brian D. Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian D. Koh. Brian D. Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Aggarwal, Rahul, Alexander Starodub, Brian D. Koh, et al.. (2022). Phase Ib Study of the BET Inhibitor GS-5829 as Monotherapy and Combined with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer. Clinical Cancer Research. 28(18). 3979–3989. 18 indexed citations
2.
3.
Pratz, Keith W., Brian D. Koh, Anand G. Patel, et al.. (2016). Poly (ADP-Ribose) Polymerase Inhibitor Hypersensitivity in Aggressive Myeloproliferative Neoplasms. Clinical Cancer Research. 22(15). 3894–3902. 23 indexed citations
4.
Roddy, Gavin W., Justin D. Kreuter, Brian D. Koh, & Andrew J. Barkmeier. (2016). Central retinal vein occlusion after plateletpheresis. Transfusion. 56(6). 1258–1258. 2 indexed citations
5.
Ding, Husheng, Kevin L. Peterson, Cristina Correia, et al.. (2016). Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells. Leukemia. 31(7). 1593–1602. 27 indexed citations
6.
Gopal, Ajay K., Brad S. Kahl, Christopher R. Flowers, et al.. (2015). Activity of Idelalisib in High-Risk Follicular Lymphoma with Early Relapse Following Front Line Immunochemotherapy. Blood. 126(23). 2744–2744. 8 indexed citations
7.
Meng, X. Wei, Brian D. Koh, Jin‐San Zhang, et al.. (2014). Poly(ADP-ribose) Polymerase Inhibitors Sensitize Cancer Cells to Death Receptor-mediated Apoptosis by Enhancing Death Receptor Expression. Journal of Biological Chemistry. 289(30). 20543–20558. 49 indexed citations
8.
Chaudhuri, Leena, Nicole D. Vincelette, Brian D. Koh, et al.. (2013). CHK1 and WEE1 inhibition combine synergistically to enhance therapeutic efficacy in acute myeloid leukemia ex vivo. Haematologica. 99(4). 688–696. 63 indexed citations
9.
Schenk, Erin L., Brian D. Koh, Karen S. Flatten, et al.. (2012). Effects of Selective Checkpoint Kinase 1 Inhibition on Cytarabine Cytotoxicity in Acute Myelogenous Leukemia Cells In Vitro. Clinical Cancer Research. 18(19). 5364–5373. 43 indexed citations
10.
McDevitt, Michael A., Brian D. Koh, Anand G. Patel, et al.. (2011). Genetic and Epigenetic Defects in DNA Repair Lead to Synthetic Lethality of Poly (ADP-Ribose) Polymerase (PARP) Inhibitors in Aggressive Myeloproliferative Disorders. Blood. 118(21). 400–400. 4 indexed citations
11.
Gupta, Mamta, Andrea E. Wahner Hendrickson, Jing Han, et al.. (2011). Dual mTORC1/mTORC2 inhibition diminishes Akt activation and induces Puma-dependent apoptosis in lymphoid malignancies. Blood. 119(2). 476–487. 82 indexed citations
12.
Shotwell, J. Brad, et al.. (2002). Inhibitors of NF-κB signaling: design and synthesis of a biotinylated isopanepoxydone affinity reagent. Bioorganic & Medicinal Chemistry Letters. 12(23). 3463–3466. 11 indexed citations
13.
Koh, Brian D. & Craig M. Crews. (2002). Chemical Genetics. Neuron. 36(4). 563–566. 14 indexed citations
14.
Shotwell, J. Brad, John Hines, Brian D. Koh, et al.. (2002). Total Synthesis of Luminacin D. Organic Letters. 4(18). 3087–3089. 24 indexed citations
15.
16.
Kwok, Benjamin H., Brian D. Koh, MacKevin Ndubuisi, Mikael Elofsson, & Craig M. Crews. (2001). The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhibits IκB kinase. Chemistry & Biology. 8(8). 759–766. 432 indexed citations
17.
Martin, Katherine J., Lorne M. Price, Brian D. Koh, et al.. (2000). Linking gene expression patterns to therapeutic groups in breast cancer.. PubMed. 60(8). 2232–8. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Linda Rickardson Breakdown of academic impact, for papers by Sundar Neelakantan Breakdown of academic impact, for papers by Peng Zou Breakdown of academic impact, for papers by Mohamed Elgendy Breakdown of academic impact, for papers by Nengming Lin Breakdown of academic impact, for papers by Donghwa Kim Breakdown of academic impact, for papers by Joanna Zawacka‐Pankau Breakdown of academic impact, for papers by Jayshree L. Hirpara Breakdown of academic impact, for papers by Ayse Batova Breakdown of academic impact, for papers by Manuela Gridling
Rankless by CCL
2026